Neuronal stimulation‐regulated RNA splicing defects in tauopathies are corrected by treatment with a p75 NTR modulator.

MLA

Latif, Hernandez, Amira, et al. “Neuronal Stimulation‐regulated RNA Splicing Defects in Tauopathies Are Corrected by Treatment with a P75 NTR Modulator.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, no. 21, Dec. 2023, pp. 1–2. EBSCOhost, https://doi.org/10.1002/alz.080548.

APA

Latif, H. A., Moran, L. P., Yang, T., White, H., Tran, K. C., Liu, H., Massa, S. M., Wyss, C. T., & Longo, F. M. (2023). Neuronal stimulation‐regulated RNA splicing defects in tauopathies are corrected by treatment with a p75 NTR modulator. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19(21), 1–2. https://doi.org/10.1002/alz.080548

Chicago

Latif, Hernandez, Amira, Losada, Patricia Moran, Tao Yang, Halle White, Kevin C Tran, Harry Liu, Stephen M. Massa, Coray, Tony Wyss, and Frank M. Longo. 2023. “Neuronal Stimulation‐regulated RNA Splicing Defects in Tauopathies Are Corrected by Treatment with a P75 NTR Modulator.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (21): 1–2. doi:10.1002/alz.080548.